
When I'm not playing doctor for Bret Michaels I'm smoking a cigar, while seeking truths. I'm a deal junkie who loves investing. Instagram:Classicroytwa #IFB
Beverly Hills, CA
Joined January 2011
- Tweets84.6K
- Following20.9K
- Followers19.2K
- Likes61.9K
AI analysis flagged this bearish $BROS bear put spread for members, and it had already paid +22.06% in 10 trading days.
↘️ Block: $41 Nov 6 put, 2,998 contracts vs 1,402 OI
➡️ Premium: $2.49M calls vs $2.48M puts, only +$8.1K net
↘️ Extension: $32.5 Apr 16 put, 1,064 contracts vs 580 OI
↘️ Level: $40-$41 shelf to watch next week; the $41 put anchored the downside line
#DayTrading #Analytics #OptionsTrading #CrestrockAdvisors
The week left $MSTR in a split tape: every one of the $27.32M in visible prints was dark-pool accumulation, while puts still outpaced calls 59% to 41%.
↘️ Options: $18.72M puts vs $13.25M calls, 59% put flow
↗️ Dark pool: $27.32M, 100% dark, bids repeated at $128.78-$128.80
↘️ Technicals: 128.93 below EMA21/50/200, RSI 41.35
➡️ Level: $128.78-$129.30 shelf to watch into next week; $135.63 and $142.54 overhead – at Cathedral City, CA
Pancreatic cancer is usually found too late. We're building around when to look.
Five-year survival is over 80% at stage 1A and about 3% once it has spread, yet fewer than 1 in 7 cases are caught while localized (Shen et al., J Clin Invest, 2025). CA 19-9 alone can't fix that: its positive predictive value is under 1%.
Our Pancreatic Risk Score combines tumor DNA, cancer-linked proteins, and patient risk factors in a two-stage funnel:
1️⃣ At-home fingertip sample, tuned for sensitivity
2️⃣ Confirmatory blood draw, tuned for specificity
3️⃣ Imaging only for the confirmed few
The goal: answer who should be imaged? It's pancreas-specific and keeps learning, with expert review of every new marker.
Early AUC of ~0.98 is from retrospective public data only, not yet externally or prospectively validated. The score is investigational, not FDA cleared, and not for clinical use.
Investors focused on early detection: I'd welcome a conversation.
#PancreaticCancer #EarlyDetection #LiquidBiopsy #Biotech
earlysignaldiagnostics.com – at Cathedral City, CA
November 6: #CrestrockAdvisors
#LatestStocksToTrade
$BABA (Alibaba) — Do not buy
$APP (AppLovin) — Do not buy
$MSFT (Microsoft) — Do not buy
$SNDK (SanDisk) — Buy at $858–$864
$MU (Micron Technology) — Buy at $680–$690
$MRVL (Marvell Technology) — Buy at $135–$140
#DayTrading #OptionsTrading #Analytics
$CSCO just lit up with a fresh $1.79M Nov 20 $105 call block. 4.2x open interest into next week's earnings.
↗️ #Options: $1.79M calls vs $0 puts, 100% unusual share
➡️ #Darkpool: $126.03M notional, heavy accumulation near $95.72-$96.76
↘️ Price/news: $94.61, down 13.29% over 5D; Morgan Stanley cut CSCO to Equal-weight
➡️ Level to watch: $95-$97; above it the call side stays in control, below it the put flow gets paid
#CrestrockAdvisors #Analytics #OptionsTrading #DayTrading
$COST
06 NOV 26 $1,080 CALL
$0.28
#Crestrockadvisors #wealthcoach #OptionsTrading
ALL-TIME HIGH BREAKOUT
Nine of 11 visible names are 0% put flow, but $MRNA is the biggest premium line at $1.6M and it’s 100% #puts.
↗️ Momentum: $HDB leads at 3.37x with 3.7K contracts and $1.1M premium
↗️ Breadth: 9 of 11 visible names show 0% put flow
↘️ Counterflow: $CNR is 100% puts, 1.8x momentum, 760 contracts, $478.8K premium
➡️ Watch: the 100% put-flow line is still just $MRNA and $CNR; if it widens, this stops reading like a clean call tape
🚨 Trade Alert
spx 7430 target
$XSP 743C 11/06 @ 1.60
#Crestrockadvisors #wealthcoach #OptionsTrading #investing #StocksToTrade #Analytics #tradingAIgorythm
📊 $SPY Trade Plan
🐂 Calls: Above 736 → 740, 742
🐻 Puts: Below 733 → 730, 728
Good luck and trade safe!
##Crestrockadvisors #wealthcoach #OptionsTrading #investing #StocksToTrade #Analytics #tradingAIgorythm #Chartpatterns #ETFs
















